v3.26.1
RESEARCH AND DEVELOPMENT EXPENSES
3 Months Ended
Jun. 30, 2026
Research and Development [Abstract]  
RESEARCH AND DEVELOPMENT EXPENSES

3. RESEARCH AND DEVELOPMENT EXPENSES

 

Our research and development costs are expensed as incurred and consist of costs associated with clinical trials, preclinical research, personnel, including salaries, payroll taxes and employee benefits, consulting and professional fees, and other expenditures incurred to support the development of the Hemopurifier. Research and development expenses are included in various operating expense line items in the accompanying condensed consolidated statements of operations.

 

Research and development expenses were as follows:

      
Amounts presented are rounded to the nearest thousand  June 30,  June 30,
    2026    2025 
Three months ended  $549,000   $524,000